Clinical characteristics of patients with B-cell NHL
| Patient no. . | Histologic diagnosis . | Sex, age, y . | Tissue used . |
|---|---|---|---|
| 1 | DLBCL | M, 61 | Node (new*) |
| 2 | High-grade transformation of CLL (DLBCL) | M, 54 | Node, PBMC |
| 3 | High-grade transformation of CLL (DLBCL) | F, 59 | Node, PBMC |
| 4 | MZL | F, 76 | Spleen, PBMC (new) |
| 5 | Follicular NHL, grade 1 | M, 52 | Node (new) |
| 6 | Relapsed Burkitt lymphoma | M, 17 | PBMC |
| 7 | Follicular NHL, grade II | M, 53 | Node, PBMC (new) |
| 8 | PTLD post-MUD transplantation for CML (DLBCL) | M, 27 | Node (new) |
| 9 | Mantle cell lymphoma | M, 76 | Node (new) |
| 10 | Follicular NHL | F, 93 | Node (new) |
| 11 | DLBCL | M, 69 | Node |
| 12 | Mantle cell lymphoma | M, 67 | Spleen, PBMC (new) |
| 13 | DLBCL | M, 56 | Node, PBMC (new) |
| 14 | MZL | F, 57 | Node (new) |
| 15 | DLBCL | F, 84 | Node, PBMC (new) |
| 16 | Small cell lymphocytic lymphoma | M, 67 | Node, PBMC (new) |
| 17 | Gastric DLBCL | M, 80 | PBMC (new) |
| 18 | MZL | M, 73 | Spleen, PBMC (new) |
| 19 | Pancreatic head DLBCL | M, 77 | PBMC (new) |
| 20 | Primary CNS DLBCL | M, 37 | PBMC (new) |
| 21 | DLBCL | M, 78 | PBMC (new) |
| 22 | Follicular NHL in leukemic phase | F, 83 | PBMC (new) |
| 23 | DLBCL | M, 46 | PBMC (new) |
| 24 | Small cell lymphocytic lymphoma | M, 48 | PBMC (new) |
| 25 | Follicular NHL | F, 56 | PBMC (new) |
| 26 | CNS DLBCL, previously treated nodal DLBCL | F, 55 | PBMC |
| 27 | DLBCL, previous low-grade NHL | F, 69 | PBMC |
| 28 | Follicular NHL | M, 66 | Node, PBMC (new) |
| 29 | Relapsed DLBCL, previous autologous transplantation | F, 61 | PBMC |
| 30 | DLBCL transformation from previous follicular NHL | M, 73 | PBMC |
| Patient no. . | Histologic diagnosis . | Sex, age, y . | Tissue used . |
|---|---|---|---|
| 1 | DLBCL | M, 61 | Node (new*) |
| 2 | High-grade transformation of CLL (DLBCL) | M, 54 | Node, PBMC |
| 3 | High-grade transformation of CLL (DLBCL) | F, 59 | Node, PBMC |
| 4 | MZL | F, 76 | Spleen, PBMC (new) |
| 5 | Follicular NHL, grade 1 | M, 52 | Node (new) |
| 6 | Relapsed Burkitt lymphoma | M, 17 | PBMC |
| 7 | Follicular NHL, grade II | M, 53 | Node, PBMC (new) |
| 8 | PTLD post-MUD transplantation for CML (DLBCL) | M, 27 | Node (new) |
| 9 | Mantle cell lymphoma | M, 76 | Node (new) |
| 10 | Follicular NHL | F, 93 | Node (new) |
| 11 | DLBCL | M, 69 | Node |
| 12 | Mantle cell lymphoma | M, 67 | Spleen, PBMC (new) |
| 13 | DLBCL | M, 56 | Node, PBMC (new) |
| 14 | MZL | F, 57 | Node (new) |
| 15 | DLBCL | F, 84 | Node, PBMC (new) |
| 16 | Small cell lymphocytic lymphoma | M, 67 | Node, PBMC (new) |
| 17 | Gastric DLBCL | M, 80 | PBMC (new) |
| 18 | MZL | M, 73 | Spleen, PBMC (new) |
| 19 | Pancreatic head DLBCL | M, 77 | PBMC (new) |
| 20 | Primary CNS DLBCL | M, 37 | PBMC (new) |
| 21 | DLBCL | M, 78 | PBMC (new) |
| 22 | Follicular NHL in leukemic phase | F, 83 | PBMC (new) |
| 23 | DLBCL | M, 46 | PBMC (new) |
| 24 | Small cell lymphocytic lymphoma | M, 48 | PBMC (new) |
| 25 | Follicular NHL | F, 56 | PBMC (new) |
| 26 | CNS DLBCL, previously treated nodal DLBCL | F, 55 | PBMC |
| 27 | DLBCL, previous low-grade NHL | F, 69 | PBMC |
| 28 | Follicular NHL | M, 66 | Node, PBMC (new) |
| 29 | Relapsed DLBCL, previous autologous transplantation | F, 61 | PBMC |
| 30 | DLBCL transformation from previous follicular NHL | M, 73 | PBMC |
DLBCL indicates diffuse large B-cell lymphoma; CLL, chronic lymphocytic leukemia; MZL, marginal zone lymphoma; NHL, non-Hodgkin lymphoma; PTLD, posttransplantation lymphoproliferative disease; MUD transplantation, matched unrelated donor transplantation; CML, chronic myeloid leukemia; and CNS, central nervous system.
New refers to a diagnosis of lymphoma with no previous history of lymphoproliferative disease.